Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre

Journal of Clinical Neuroscience

Volumn 16, Issue 9, 2009, Pages 1174-1179

  Gauden, Andrew J ^a   Hunn, Andrew ^a   Erasmus, Albert ^a   Waites, Pauline ^a   Dubey, Arvind ^a   Gauden, Stanislaw J ^b  

^a ROYAL HOBART HOSPITAL   (Australia)

^b WP Holman Clinic   (Australia)

Author keywords

Glioblastoma; Glioma; Radiotherapy; Resection; Surgery; Temozolomide

Indexed keywords

ANTICONVULSIVE AGENT; STEROID; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FEMALE; GLIOBLASTOMA; HUMAN; KAPLAN MEIER METHOD; MALE; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PETECHIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RASH; RETROSPECTIVE STUDY; SEIZURE; STUPP PROTOCOL; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HOSPITALS, COMMUNITY; HUMANS; KAPLAN-MEIERS ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SURVIVAL;

EID: 67650732135     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.12.008     Document Type: Article

References (40)

1. Mirimanoff R., Gorlia T., Mason W., et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24 (2006) 2563-2569
2. DeAngelis L. Brain tumors. N Engl J Med 344 (2001) 114-123
3. Brada M., Sharpe G., Rajan B., et al. Modifying radical radiotherapy in high grade gliomas. Shortening the treatment time through acceleration. Int J Radiat Oncol Biol Phys 43 (1999) 287-292
4. Reni M., Cozzarini C., Ferreri A., et al. A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme. Cancer Invest 18 (2000) 510-515
5. Shibamoto Y., Yamashita J., Takahashi M., et al. Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother Oncol 18 (1990) 9-17
6. Stupp R., Mason W., Bent M.V.D., et al. Radiotherapy plus cocomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
7. Dinapoli R., Brown L., Arusell R., et al. Phase III comparitive evaluation of PCNY and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol 11 (1993) 1316
8. Black P. Brain tumors (first of two parts). N Engl J Med 38 (1991) 1374
9. Berger M. Malignant astrocytomas. Surgical aspects. Semin Oncol 21 (1994) 172
10. Vuorinen V., Hinkka S., and Farkkila M. Debulking or biopsy of malignant glioma in elderly people-a randomised study. Acta Neurochir (Wien) 145 (2003) 5-10
11. Hess K.R. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42 (1999) 227-231
12. Combs S.E., Wagner J., Bischof M., et al. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 70 (2008) 987-992
13. Algan O., Nelson D., DInapoli R., et al. High-grade gliomas. In: Gunderson L., and Tepper J. (Eds). Clinical Radiation Oncology (2001), Churchill Livingstone, Pennsylvania 355-377
14. Pollack L., Gur R., Walach N., et al. Clinical determinants of long-term survival in patients with glioblastoma multiforme. Tumori 83 (1997) 613-617
15. Kreth F., Warnke P., Scheremet R., et al. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78 (1993) 762-766
16. Yuile P., Dent O., Cook R., et al. Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables. J Clin Neurosci 13 (2006) 747-751
17. Coombs S., Gutwein S., Schulz-Ertner D., et al. Temozolomide combined with irradiation as post-operative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlenther Onkol 181 (2005) 372-377
18. Patwardhan R., Shorter C., Willis B., et al. Survival trends in elderly patients with glioblastoma multiforme: Resective surgery, radiation, and chemotherapy. Surg Neurol 62 (2004) 207-213
19. Quigley M., and Maroon J. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29 (1991) 385
20. Devaux B., O'Fallon J., and Kelly P. Resection, biopsy, and survival in malignant glial neoplasma. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78 (1993) 767
21. Laws E., Parney I., Huang W., et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99 (2003) 467
22. Green S., Byar D., Walker M., et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67 (1983) 121
23. Lamborn K., Chang S., and Prados M. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro-oncol 6 (2004) 227
24. Karnofsky D., and Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C. (Ed). Evaluation of Chemotherapeutic Agents (1949), Columbia University Press 196
25. Oken M., Creech R., Tormey D., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
26. Hoshino T. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 61 (1984) 895-900
27. Nader S., and Mitchel B. Glioma extent of resection and its impact on patient outcome. Neurosurgery 62 (2008) 753-766
28. Vives K., and Piepmeier J. Complications and expected outcome of glioma surgery. J Neuro-Oncol 42 (1999) 289-302
29. Coffey R., Lunsford L., and Taylor F. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 22 (1988) 465
30. Duncan C., Goodman G., Ludgate C., et al. The treatment of adult supratentorial high grade astrocytomas. J Neurooncol 13 (1992) 63
31. Sandberg-Wollheim M., Malmstrom P., Stromblad L.-G., et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 68 (1991) 22-29
32. Wood J., Green S., and Shapiro W. The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6 (1988) 338
33. Simpson J., Horton J., Scott C., et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26 (1993) 239
34. LaCroix M., Abi-Said D., Fourney D., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95 (2001) 190
35. Bucci M., Maity A., Janss A., et al. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer 101 (2004) 817
36. Nakagawa K., Aoki Y., Fujimaki T., et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40 (1998) 1141-1149
37. Shinoda J., Sakai N., Murase S., et al. Selection of eligible patients with glioblastoma multiforme for gross total resection. J Neuro-Oncol 52 (2001) 161-171
38. Ozbek N., Cakir S., Gursel B., et al. Prognostic significance of seizure in patients with glioblastoma multiforme. Neurol India 52 (2004) 76-78
39. Frankel S., and German S. Glioblastoma multiforme. Review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment. J Neurosurg 15 (1958) 489-503
40. Roth J., and Elvidge A. Glioblastoma multiforme: A clinical survey. J Neurosurg 17 (1959) 236-250